Management of Anteriorly Migrated Fluocinolone 0.18- & 0.19-mg Implants Using Scleral Suture Fixation With and Without Concomitant Implantation of A Fluocinolone 0.59-mg Implant.

PURPOSE: To demonstrate two surgical fixation techniques to salvage anteriorly migrated fluocinolone acetonide implants (Yutiq; Alimera Sciences Limited, Alpharetta, GA) (Iluvien; Alimera Sciences Limited, Alpharetta, GA - Both assets were acquired by ANI Pharmaceuticals, Princeton, NJ, since this artical was initially written).

METHODS

Anteriorly dislocated steroid implant pellets were retrieved and successfully suture-fixated to the pars plana or to a newly implanted 0.59-mg fluocinolone acetonide implant (Retisert; Bausch & Lomb, Rochester, NY) with nonabsorbable suture to securely reposition them into the vitreous compartment.

RESULTS

Both presented techniques successfully refixated implants, which remained fixated at long-term follow-up for all patients. All patients tolerated the procedures well with no adverse outcomes or complications from refixation.

CONCLUSIONS

The presented surgical techniques offer novel and effective methods to manage anteriorly migrated steroid implants.